GT200700097A - Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- GT200700097A GT200700097A GT200700097A GT200700097A GT200700097A GT 200700097 A GT200700097 A GT 200700097A GT 200700097 A GT200700097 A GT 200700097A GT 200700097 A GT200700097 A GT 200700097A GT 200700097 A GT200700097 A GT 200700097A
- Authority
- GT
- Guatemala
- Prior art keywords
- disease
- phenylpiridinylpiperazine
- pharmaceutical compositions
- compositions containing
- new derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 201000011240 Frontotemporal dementia Diseases 0.000 abstract 1
- 208000006264 Korsakoff syndrome Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS DERIVADOS DE FENILPIRIDINILPIPERAZINA, ASÍ COMO PROCEDIMIENTO PARA SU PREPARACIÓN Y COMPOSICIONES FARMACÈUTICAS QUE LOS CONTIENEN, INCLUYENDO SUS ISÓMEROS Y SUS RESPECTIVAS SALES DE ADICIÓN. DICHOS COMPUESTOS SE UTILIZAN COMO MEDICAMENTO EN EL TRATAMIENTO DE DÉFICITS COGNITIVOS ASOCIADOS A LA ENFERMEDAD DE ALZHEIMER, ENFERMEDAD DE PARKINSON, ENFERMEDAD DE PICK, ENFERMEDAD DE KORSAKOFF Y DEMENCIAS FRONTALES Y SUBCORTICALES DE ORÍGENES VASCULARES U OTROS. ASÍ COMO PROBLEMAS ASOCIADOS AL ENVEJECIMIENTO CEREBRAL Y ENFERMEDADES NEURODEGENERATIVAS. T2007
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0504758A FR2885616B1 (fr) | 2005-05-12 | 2005-05-12 | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2006/001050 WO2006120349A1 (fr) | 2005-05-12 | 2006-05-11 | Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200700097A true GT200700097A (es) | 2009-06-04 |
Family
ID=35668833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200700097A GT200700097A (es) | 2005-05-12 | 2007-11-07 | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7494994B2 (es) |
| EP (1) | EP1721897A1 (es) |
| JP (1) | JP2006316061A (es) |
| KR (1) | KR100807481B1 (es) |
| CN (1) | CN100569767C (es) |
| AP (1) | AP2007004223A0 (es) |
| AR (1) | AR054121A1 (es) |
| AU (1) | AU2006201994A1 (es) |
| BR (1) | BRPI0601773A (es) |
| CA (1) | CA2546392A1 (es) |
| CR (1) | CR9499A (es) |
| EA (1) | EA011155B1 (es) |
| FR (1) | FR2885616B1 (es) |
| GE (1) | GEP20084470B (es) |
| GT (1) | GT200700097A (es) |
| IL (1) | IL186862A0 (es) |
| MA (1) | MA28326A1 (es) |
| MY (1) | MY141784A (es) |
| NO (1) | NO20062083L (es) |
| NZ (1) | NZ547122A (es) |
| SG (1) | SG127801A1 (es) |
| TN (1) | TNSN07395A1 (es) |
| UA (1) | UA87284C2 (es) |
| WO (1) | WO2006120349A1 (es) |
| ZA (1) | ZA200603810B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
| RU2499795C2 (ru) * | 2005-07-04 | 2013-11-27 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| WO2007137968A1 (en) * | 2006-05-29 | 2007-12-06 | High Point Pharmaceuticals, Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
| EA200970583A1 (ru) * | 2006-12-14 | 2009-12-30 | Янссен Фармацевтика Н.В. | Способ получения пиперазиниловых и диазепаниловых производных бензамида |
| EP2014656A3 (en) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
| CU24177B1 (es) | 2011-02-23 | 2016-04-25 | Lupin Ltd | Derivados de heteroarilo como moduladores de nachr alfa 7 |
| EP2822946A1 (en) | 2012-03-06 | 2015-01-14 | Lupin Limited | Thiazole derivatives as alpha 7 nachr modulators |
| EP3373935B1 (en) * | 2015-11-12 | 2021-09-01 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0361489A3 (en) * | 1988-09-30 | 1991-06-12 | Chugai Seiyaku Kabushiki Kaisha | Novel 3,4-diaminoquinoline and pyridine compounds |
| JPH06501019A (ja) * | 1990-09-13 | 1994-01-27 | スミスクライン・ビーチャム・コーポレイション | ピリジルチオまたはピリジルオキシアルカン酸 |
| DE69720021T2 (de) * | 1996-10-04 | 2004-02-05 | Novo Nordisk A/S | 1,4-disubstituierte piperazine |
| ATE404539T1 (de) * | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
| HU226859B1 (en) * | 1997-10-27 | 2009-12-28 | Neurosearch As | Phenyl- or heteroaryl-homopiperazines, their use and medicaments containing them |
| GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
| US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
-
2005
- 2005-05-12 FR FR0504758A patent/FR2885616B1/fr not_active Expired - Fee Related
-
2006
- 2006-05-02 MA MA28997A patent/MA28326A1/fr unknown
- 2006-05-05 SG SG200603045A patent/SG127801A1/en unknown
- 2006-05-09 NO NO20062083A patent/NO20062083L/no not_active Application Discontinuation
- 2006-05-10 MY MYPI20062154A patent/MY141784A/en unknown
- 2006-05-11 NZ NZ547122A patent/NZ547122A/en unknown
- 2006-05-11 EP EP06290758A patent/EP1721897A1/fr not_active Withdrawn
- 2006-05-11 US US11/432,250 patent/US7494994B2/en not_active Expired - Fee Related
- 2006-05-11 AR ARP060101889A patent/AR054121A1/es unknown
- 2006-05-11 UA UAA200605182A patent/UA87284C2/ru unknown
- 2006-05-11 AP AP2007004223A patent/AP2007004223A0/xx unknown
- 2006-05-11 WO PCT/FR2006/001050 patent/WO2006120349A1/fr active Application Filing
- 2006-05-11 GE GEAP20069393A patent/GEP20084470B/en unknown
- 2006-05-12 BR BRPI0601773-8A patent/BRPI0601773A/pt not_active IP Right Cessation
- 2006-05-12 ZA ZA200603810A patent/ZA200603810B/xx unknown
- 2006-05-12 CA CA002546392A patent/CA2546392A1/fr not_active Abandoned
- 2006-05-12 CN CNB2006101263989A patent/CN100569767C/zh not_active Expired - Fee Related
- 2006-05-12 EA EA200600760A patent/EA011155B1/ru not_active IP Right Cessation
- 2006-05-12 JP JP2006133322A patent/JP2006316061A/ja active Pending
- 2006-05-12 KR KR1020060042839A patent/KR100807481B1/ko not_active IP Right Cessation
- 2006-05-12 AU AU2006201994A patent/AU2006201994A1/en not_active Abandoned
-
2007
- 2007-10-23 IL IL186862A patent/IL186862A0/en unknown
- 2007-10-24 TN TNP2007000395A patent/TNSN07395A1/en unknown
- 2007-11-05 CR CR9499A patent/CR9499A/es not_active Application Discontinuation
- 2007-11-07 GT GT200700097A patent/GT200700097A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100807481B1 (ko) | 2008-02-25 |
| CN1896073A (zh) | 2007-01-17 |
| US20060258670A1 (en) | 2006-11-16 |
| KR20060117263A (ko) | 2006-11-16 |
| MY141784A (en) | 2010-06-30 |
| US7494994B2 (en) | 2009-02-24 |
| NO20062083L (no) | 2006-11-13 |
| TNSN07395A1 (en) | 2009-03-17 |
| UA87284C2 (ru) | 2009-07-10 |
| EA200600760A1 (ru) | 2006-12-29 |
| GEP20084470B (en) | 2008-08-25 |
| CA2546392A1 (fr) | 2006-11-12 |
| JP2006316061A (ja) | 2006-11-24 |
| FR2885616A1 (fr) | 2006-11-17 |
| MA28326A1 (fr) | 2006-12-01 |
| ZA200603810B (en) | 2007-08-29 |
| SG127801A1 (en) | 2006-12-29 |
| AR054121A1 (es) | 2007-06-06 |
| EA011155B1 (ru) | 2009-02-27 |
| AU2006201994A1 (en) | 2006-11-30 |
| CR9499A (es) | 2008-02-20 |
| AP2007004223A0 (en) | 2007-10-31 |
| CN100569767C (zh) | 2009-12-16 |
| FR2885616B1 (fr) | 2007-06-22 |
| NZ547122A (en) | 2007-05-31 |
| EP1721897A1 (fr) | 2006-11-15 |
| WO2006120349A1 (fr) | 2006-11-16 |
| IL186862A0 (en) | 2008-02-09 |
| BRPI0601773A (pt) | 2007-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200700097A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| DOP2006000205A (es) | Derivados de fenil-1,2,4-oxadiazolona con grupo fenilo, procedimientos para su preparacion y su uso como productos farmaceuticos. | |
| UY34239A (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
| ECSP066730A (es) | Compuestos y procedimientos para uso | |
| DOP2009000258A (es) | Compuestos amino-heterociclicos | |
| ECSP066734A (es) | Derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico, métodos para su producción y su uso como medicamentos | |
| CO6362014A2 (es) | Compuestos con anillos espiro - triciclicos como moduladores de beta-secretasaa y metodos de uso | |
| AR065135A1 (es) | Compuestos triciclicos, composicion que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el receptor de glucocorticoides. | |
| CR20130339A (es) | Nuevos derivados heterocíclicos y su uso en el tratamiento de desordenes neurológicos | |
| CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
| PA8604201A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
| UY28837A1 (es) | Oxadiazolonas procedimientos para su preparación y su uso como productos farmacéuticos. | |
| UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
| CL2011002766A1 (es) | Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras. | |
| UY28825A1 (es) | Compuestos de sulfonamidas para el tratamiento de trastornos neurodegenerativos | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| ECSP11010956A (es) | Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos | |
| UY30029A1 (es) | Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| DOP2010000317A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
| BRPI0606140A2 (pt) | tiazolidinonas, preparação e uso das mesmas como medicamento | |
| UY29846A1 (es) | N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas, procesos para su preparación y su uso como productos farmacéuticos | |
| UY29394A1 (es) | Derivados sustituidos de n-(5-(2-propilamino.1.hidroxietil)-2-hdroxifenil) metano sulfonamida, composiciones farmacéuticas que lo contienen y aplicaciónes. | |
| UY28209A1 (es) | Derivados de aminoácidos con cicloalquilo, procedimiento para su preparación y su uso como medicamentos. | |
| UY29847A1 (es) | N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos. |